Evidence map›Paper›PMID 38712244›Full record

ArticleResearch square2024

OTULIN-related conditions: Report of a new case and review of the literature using GenIA.

Andrés Caballero-Oteyza, Laura Crisponi, Xiao P Peng, Hongying Wang, Pavla Mrovecova, Stefania Olla, Chiara Siguri, Farida Marnissi, Zineb Jouhadi, Ivona Aksentijevich and 2 more

Abstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in Research square, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Andrés Caballero-OteyzaClinic for Immunology and Rheumatology, Hanover Medical School, Hanover, Germany.
Laura CrisponiInstitute for Genetic and Biomedical Research (IRGB), The National Research Council (CNR), Monserrato, Cagliari, Italy.
Xiao P PengDepartment of Genetic Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Hongying WangInflammatory Disease Section, National Human Genome Research Institute, Bethesda, Maryland, USA.
Pavla MrovecovaInstitute for Immunodeficiency, Center for Chronic Immunodeficiency, University Hospital Freiburg, Freiburg, Germany.
Stefania OllaInstitute for Genetic and Biomedical Research (IRGB), The National Research Council (CNR), Monserrato, Cagliari, Italy.
Chiara SiguriInstitute for Genetic and Biomedical Research (IRGB), The National Research Council (CNR), Monserrato, Cagliari, Italy.
Farida MarnissiPathology Center university hospital, Ibn Rochd, University Hassan 2, Casablanca, Morocco.
Zineb JouhadiLaboratory of Cellular and Molecular Pathology, Immunopathology of Infectious and System Diseases, Department of Infectious Diseases, University Children's Hospital Ibn Rochd, University Hassan 2, Casablanca, Morocco.
Ivona AksentijevichInflammatory Disease Section, National Human Genome Research Institute, Bethesda, Maryland, USA.
Bodo GrimbacherInstitute for Immunodeficiency, Center for Chronic Immunodeficiency, University Hospital Freiburg, Freiburg, Germany.
Michele ProiettiClinic for Immunology and Rheumatology, Hanover Medical School, Hanover, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

autoinflammationGenIAhuman geneticsIMD107immunodeficiencyNF-κBORASOTULINOTULIN haploinsufficiencySystematic reviewubiquitin

Identifiers

PMID38712244
PMCPMC11071612

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.